Verifying...

Loading, please wait...

About Us Contact Us FAQs Privacy Policy Terms of Use ISO

Download Our App

Copyright © 2026 Omnicuris Healthcare Pvt Ltd. All rights reserved.

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris

MedShots Help Profile

Speciality

Oncology

CMEs/CPDs

COVID AND ONCOLOGY- An Exclusive session by TMC

Basics Of Clinical Oncology

MasterSeries - Early Diagnosis, Disease Management & Patient Care in Cancer

Updates in Gynecological Cancers: Clinical Perspectives

Advanced Clinical Oncology

Changing Paradigms in ENT Practice - Focus on Allergy, Head and Neck Cancer and Nasal Surgeries

Cervical Cancer Advanced

Lymphoma- An Exclusive session by TMC

Game Changers in Breast Cancer Treatment

Ovarian Cancer

Trending MedShots

Combining BCG and Immune Checkpoint Inhibitors in High-Risk NMIBC

Combining BCG and Immune Checkpoint Inhibitors in High-Risk NMIBC

Read More

20 hours agoRead more

Agreement Between CT-Based Body Composition Software and Qualitative Muscle Assessment

Agreement Between CT-Based Body Composition Software and Qualitative Muscle Assessment

Read More

20 hours agoRead more

AI-Driven Structural Mapping of Reversible LSD1 Inhibitors

AI-Driven Structural Mapping of Reversible LSD1 Inhibitors

Read More

23 hours agoRead more

Transferrin-Functionalized Liposomes: Advancing Targeted Breast Cancer Therapy

Transferrin-Functionalized Liposomes: Advancing Targeted Breast Cancer Therapy

Read More

1 day agoRead more

New Research: IL-8 and Extracellular Vesicles Drive Senescence in LAM

New Research: IL-8 and Extracellular Vesicles Drive Senescence in LAM

Read More

1 day agoRead more

Combining BCG and Immune Checkpoint Inhibitors in High-Risk NMIBC

Combining BCG and Immune Checkpoint Inhibitors in High-Risk NMIBC

High-risk non-muscle-invasive bladder cancer (NMIBC) treatment is evolving. This review explores combining the gold standard BCG with immune checkpoint inhibitors (ICIs), analyzing biological synergy and recent Phase III trial outcomes like the POTOMAC study for bladder preservation.

20 hours agoRead more

Agreement Between CT-Based Body Composition Software and Qualitative Muscle Assessment

Agreement Between CT-Based Body Composition Software and Qualitative Muscle Assessment

20 hours agoRead more

AI-Driven Structural Mapping of Reversible LSD1 Inhibitors

AI-Driven Structural Mapping of Reversible LSD1 Inhibitors

23 hours agoRead more

Transferrin-Functionalized Liposomes: Advancing Targeted Breast Cancer Therapy

Transferrin-Functionalized Liposomes: Advancing Targeted Breast Cancer Therapy

1 day agoRead more

New Research: IL-8 and Extracellular Vesicles Drive Senescence in LAM

New Research: IL-8 and Extracellular Vesicles Drive Senescence in LAM

1 day agoRead more

OC Originals

Surgery for Lung Cancer

Impact of COVID 19 on Cancer Care in India

Immunotherapy in Cancer Management: Where Have We Reached?

World No Tobacco Day: Oncology & Pulmonology Roundtable

Legends of Medicine| Oncology

Legends of Medicine| Oncology | Padma Shri Dr. Ashok Kumar Vaid

President meets the President Elect | ISMPO

Conferences

ISMPOCON - 2018

ISNOCON Conference 2019

ISMPOCON 2020